Get the Stockscreener App
3.07
0.65%
-0.02
After Hours:
3.06
-0.010
-0.33%
Shuttle Pharmaceuticals Holdings Inc stock is traded at $3.07, with a volume of 32,310.
It is down -0.65% in the last 24 hours and down -30.54% over the past month.
Shuttle Pharmaceuticals Holdings Inc is a clinical-stage pharmaceutical company leveraging its proprietary technology to develop novel therapies designed to cure cancers. The company's goal is to extend the benefits of cancer treatments with surgery, radiation therapy, chemotherapy and immunotherapy. Radiation therapy (RT) is one of the effective modalities for treating cancers. It is developing a pipeline of products designed to address the limitations of the current cancer therapies as well as to extend to the new applications of RT. The company believes that its product candidates will enable the company to deliver cancer treatments that are safer, more reliable and at a greater scale than that of the current standard of care.
See More
Previous Close:
$3.09
Open:
$3.15
24h Volume:
32,310
Relative Volume:
0.24
Market Cap:
$3.29M
Revenue:
-
Net Income/Loss:
$-7.35M
P/E Ratio:
-6.6739
EPS:
-0.46
Net Cash Flow:
$-5.48M
1W Performance:
-15.43%
1M Performance:
-30.54%
6M Performance:
-58.60%
1Y Performance:
-90.44%
1-Day Range:
$3.01
$3.1876
1-Week Range:
$3.01
$3.75
52-Week Range:
$3.00
$56.25
Shuttle Pharmaceuticals Holdings Inc Stock (SHPH) Company Profile
Name
Shuttle Pharmaceuticals Holdings Inc
Sector
Phone
(240) 403-4212
Address
401 PROFESSIONAL DRIVE, GAITHERSBURG
Compare SHPH with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SHPH
Shuttle Pharmaceuticals Holdings Inc
|
3.07 | 3.31M | 0 | -7.35M | -5.48M | -0.46 |
|
ZTS
Zoetis Inc
|
145.94 | 64.88B | 9.39B | 2.62B | 2.22B | 5.8121 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.01 | 44.40B | 29.96B | 957.25M | 4.77B | 0.2956 |
|
HLN
Haleon Plc Adr
|
9.25 | 41.72B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
18.95 | 21.82B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
418.58 | 19.28B | 3.08B | 1.24B | 1.07B | 25.61 |
Shuttle Pharmaceuticals Holdings Inc Stock (SHPH) Latest News
Does Shuttle Pharmaceuticals Holdings Inc. show high probability of reboundPortfolio Performance Report & Stock Market Timing Techniques - newser.com
What risks investors should watch in Shuttle Pharmaceuticals Holdings Inc. stockQuarterly Trade Summary & Precise Swing Trade Alerts - newser.com
Risk adjusted return profile for Shuttle Pharmaceuticals Holdings Inc. analyzedJuly 2025 Rallies & Real-Time Volume Spike Alerts - newser.com
How Shuttle Pharmaceuticals Holdings Inc. stock reacts to inflationary pressuresQuarterly Portfolio Summary & Technical Confirmation Trade Alerts - newser.com
Can Shuttle Pharmaceuticals Holdings Inc. stock deliver surprise earnings beat2025 Top Decliners & AI Driven Stock Reports - newser.com
How Shuttle Pharmaceuticals Holdings Inc. stock performs after earnings2025 Breakouts & Breakdowns & Reliable Momentum Entry Alerts - newser.com
Analyzing recovery setups for Shuttle Pharmaceuticals Holdings Inc. investorsProduct Launch & High Return Trade Opportunity Guides - newser.com
Shuttle Pharmaceuticals to acquire Molecule.ai for $10 million - Investing.com India
Shuttle Pharmaceuticals to acquire Molecule.ai for $10 million By Investing.com - Investing.com Nigeria
Shuttle Pharmaceuticals to acquire AI firm Molecule for $10 million By Investing.com - Investing.com Australia
Shuttle Pharma and the Moment Science Learned to Think for Itself (NASDAQ:SHPH) - ACCESS Newswire
Shuttle Pharma (NASDAQ:SHPH) signs LOI to buy Molecule.ai; ~$10M, milestone-based - Stock Titan
Shuttle Pharma Positions to Become the First Self-Learning Biotech After Definitive LOI to Acquire Molecule.AI (NASDAQ:SHPH) - ACCESS Newswire
Shuttle Pharma (NASDAQ: SHPH) signs LOI to acquire Molecule.ai for $10M in cash and stock - Stock Titan
Multi factor analysis applied to Shuttle Pharmaceuticals Holdings Inc.Insider Buying & Breakout Confirmation Trade Signals - newser.com
Shuttle Pharma Turns Radiation Into a Smart Weapon With Definitive LOI for Molecule.ai (NASDAQ:SHPH) - ACCESS Newswire
Shuttle Pharma (NASDAQ: SHPH) LOI to acquire Molecule.ai assets for ~$10M cash-stock - Stock Titan
Real time scanner hits for Shuttle Pharmaceuticals Holdings Inc. explainedTrade Volume Report & Low Risk Growth Stock Ideas - newser.com
Shuttle Pharmaceuticals to acquire AI firm Molecule for $10 million - Investing.com
Shuttle Pharmaceuticals stock surges on AI acquisition plans By Investing.com - Investing.com Philippines
Shuttle Pharmaceuticals Holdings Inc Stock (SHPH) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.60%
0.27%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):